Gabelli & CO Investment Advisers, Inc. Surmodics Inc Transaction History
Gabelli & CO Investment Advisers, Inc.
- $535 Million
- Q3 2024
A detailed history of Gabelli & CO Investment Advisers, Inc. transactions in Surmodics Inc stock. As of the latest transaction made, Gabelli & CO Investment Advisers, Inc. holds 121,437 shares of SRDX stock, worth $4.78 Million. This represents 0.88% of its overall portfolio holdings.
Number of Shares
121,437
Previous 72,100
68.43%
Holding current value
$4.78 Million
Previous $3.03 Million
55.36%
% of portfolio
0.88%
Previous 0.55%
Shares
2 transactions
Others Institutions Holding SRDX
# of Institutions
126Shares Held
11.7MCall Options Held
1.4KPut Options Held
8.6K-
Black Rock Inc. New York, NY1.17MShares$46 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.04MShares$40.9 Million0.01% of portfolio
-
Beryl Capital Management LLC Redondo Beach, CA989KShares$38.9 Million14.09% of portfolio
-
Vanguard Group Inc Valley Forge, PA804KShares$31.6 Million0.0% of portfolio
-
Morgan Stanley New York, NY753KShares$29.6 Million0.0% of portfolio
About SURMODICS INC
- Ticker SRDX
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 14,005,000
- Market Cap $551M
- Description
- Surmodics, Inc., together with its subsidiaries, provides surface modification technologies for intravascular medical devices, and chemical components for in vitro diagnostic immunoassay tests and microarrays in the United States and internationally. It operates in two segments, Medical Device and In Vitro Diagnostics (IVD). The Medical Device s...